Opens in a new tab

*** v OrthoApnea (CFI, 17 January 2025)

Date17 January 2025
CourtCFI
DivisionBrussels (BE) Local Division
Type of actionInfringement Action
Registry referenceACT_581538/2023 · ORD_598478/2023
Parties*** v. OrthoApnea S.L., Vivisol B BV

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By decision on the merits of 17 January 2025 (UPC_CFI_376/2023), given in Dutch, the Brussels Local Division dismissed a Belgian orthodontist’s action against OrthoApnea and Vivisol B for literal and equivalent infringement of a European patent for a mandibular advancement device. It held that the action on the merits had been started in time after the seizure of evidence, but lifted the seizure and ordered the return of the items seized.

Facts and procedure

The claimant, the patent proprietor, had obtained on 21 September 2023 an order to preserve evidence, executed the next day against OrthoApnea, the Spanish maker of the NOA device. The expert report was lodged on 28 September 2023 (paragraph 1). The statement of claim was lodged in Dutch on 23 October 2023, OrthoApnea having refused service for want of a translation (Rule 271.8 RoP), a Spanish translation was served on it on 18 January 2024 (paragraphs 2 to 5).

In his reply the claimant added an auxiliary plea of infringement by equivalence, admitted by the judge-rapporteur and then by the Court of Appeal (paragraphs 7 to 12). The value in dispute was set at EUR 250,000 (paragraph 13). The claimant relied on claims 1, 9 and 10 (paragraphs 32 to 34).

The applicable law

The Court examines its international jurisdiction of its own motion, here founded on Articles 4(1) and 8(1) of the Brussels I recast Regulation, or on Articles 7(2) and 71b(1), the Brussels division is competent under Article 33(1)(a) UPCA (paragraphs 51 and 52).

Rule 198.1 RoP requires proceedings on the merits to be started within 31 calendar days or 20 working days, failing which the order is revoked at the defendant’s request. Under Rule 17.4 RoP the action commences on the date of receipt attributed to the statement of claim (paragraphs 57 and 63). The extent of protection is determined under Article 69 EPC and its Protocol, applicable through Article 24(1) UPCA, the claim being read by the skilled person in light of the description and drawings (paragraphs 66 to 68).

Question

Is the action on the merits started in time under Rule 198.1 RoP where only the translation of the statement of claim is served after the time limit, and does a device whose upper and lower parts meet in the occlusal plane reproduce, literally or by equivalence, a stop located in the oral vestibule?

Decision

The request to lift the seizure for lateness was first of all inconsistent, since OrthoApnea itself relied on the expert report resulting from the seizure (paragraph 55). More importantly, the action was started on 23 October 2023, when the statement of claim was uploaded to the case management system, within the 31-day period, later service of the translation is irrelevant, as otherwise a defendant could postpone that starting point by refusing service (paragraphs 60 to 64).

On the merits, features 1.2.1 and 1.2.4 require a stop and a contact surface located in the oral vestibule that prevent further closing of the mouth (paragraph 79). In the NOA device it is the upper and lower parts, meeting in the occlusal plane, that limit closure, and a gap remains between the coupling elements (paragraphs 90 to 92). One-sided contact in a lateral sleeping position does not prevent closure on the other side (paragraph 93). Literal infringement of claims 1, 9 and 10 was rejected (paragraphs 95 and 96).

As to equivalence, the absence of functional equivalence is enough to exclude it, whichever test is applied (paragraph 98). Jaw forces are here borne in the occlusal plane rather than diverted to vestibular coupling elements, the very solution from which the patent sought to distinguish the prior art (paragraphs 99 to 102).

The claimant bears the costs. The ceiling for recoverable representation costs was set at EUR 38,000, the amount and compensation for harm caused by the seizure being left to subsequent proceedings (paragraphs 105 to 113). The seizure was lifted and the items must be returned within ten working days of service (Rule 198.2 RoP, paragraphs 110 and 111).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 24(1), 32(1)(a), 33(1)(a), 54, 69(2) and 73(1)
Rules of Procedure
Rules 17.4, 118.5, 125, 150, 152.2, 196.4, 197.4, 198.1, 198.2, 271.8 and 300(a)
European Patent Convention
Art. 69 and Protocol on its interpretation
Regulation (EU) No 1215/2012
Arts 4(1), 7(2), 8(1) and 71b(1)
Case law cited
Aylo Freesites v DISH, Court of Appeal, 3 September 2024 (UPC_CoA_188/2024), NanoString v 10x Genomics, Court of Appeal, 11 March 2024 (UPC_CoA_335/2023), VusionGroup v Hanshow, Court of Appeal, 13 May 2024, Plant-e v Arkyne, The Hague Local Division, 22 November 2024 (UPC_CFI_239/2023)

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Patent infringement action.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
L'action en contrefaçon, littérale et par équivalence, est rejetée. L'action au fond a été engagée à temps au sens de la règle 198.1, mais la saisie de preuves est levée et les biens saisis doivent être restitués.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.